Amlodipine, enalapril, and dependent leg edema in essential hypertension

Hypertension

Volumn 35, Issue 2, 2000, Pages 621-625

  Pedrinelli, Roberto ^a   Dell'Omo, Giulia ^b   Melillo, Elio ^b   Mariani, Mario ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

Angiotensin converting enzyme inhibitors; Blood flow; Calcium antagonists; Hypertension, essential; Vasoconstriction

Indexed keywords

AMLODIPINE; ENALAPRIL;

ADULT; AGED; ARTICLE; AUTOREGULATION; CAPILLARY PRESSURE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; EXTRAVASATION; HUMAN; LASER FLOWMETER; LEG; LEG EDEMA; MALE; PRIORITY JOURNAL; SKIN BLOOD FLOW; VASOCONSTRICTION; WEIGHT;

EID: 0033953234     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.2.621     Document Type: Article

References (32)

1. Henriksen O. Local sympathetic reflex mechanism in regulation of blood flow in human subcutaneous adipose tissue. Acta Physiol Scand. 1977; (suppl 450):1-48.
2. Hassan AA, Tooke JE. Mechanism of the postural vasoconstrictor response in the human foot. Clin Sci (Colch). 1988;75:379-387.
3. Mellander S, Oberg B, Odelram H. Vascular adjustments to increased transmural pressure in cat and man with special reference to shifts in capillary fluid transfer. Acta Physiol Scand. 1964;61:34-48.
4. Henriksen O, Paaske WP. Local regulation of blood flow in peripheral tissue. Acta Chir Scand Suppl. 1980;502:63-74.
5. Rayman G, Hassan A, Tooke JE. Blood flow in the skin of the foot related to posture in diabetes mellitus. BMJ. 1986;292:87-90.
6. Rayman G, Williams SA, Gamble J, Tooke JE. A study of factors governing fluid filtration in the diabetic foot. Eur J Clin Invest. 1994;24: 830-836.
7. Iabichella ML, Dell'Omo G, Melillo E, Pedrinelli R. Calcium channel blockers blunt postural cutaneous vasoconstriction in hypertensive patients. Hypertension. 1997;29:931-937.
8. van Hamersvelt HW, Kloke HJ, de Jong DJ, Koene RA, Huysmans FT. Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention? J Hypertens. 1996;14:1041-1045.
9. Opie LH. Calcium channel antagonists, IV: side effects and contraindications, interactions and combinations. Cardiovasc Drugs Ther. 1988;2: 177-189.
10. Opie LH. Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine. Postgrad Med J. 1991;67(suppl 5):S2-S8.
11. Guazzi MD, De Cesare N, Galli C, Salvioni A, Tramontana C, Tamborini G, Bartorelli A. Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Circulation. 1984;70:279-284.
12. Gradman AH, Cutler NR, Davis PJ, Robbins JA, Weiss RJ, Wood BC. Combined enalapril and felodipine extended release (ER) for systemic hypertension: Enalapril-Felodipine ER Factorial Study Group. Am J Cardiol. 1997;79:431-435.
13. Davies RO, Gomez HJ, Irvin JD, Walker JF. An overview of the clinical pharmacology of enalapril. Br J Clin Pharmacol. 1984;18(suppl 2):215S-229S.
14. Nilsson GE, Tenland T, Oberg PA. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng. 1980;27:597-604.
15. Low C, Neumann PJ, Dyck RD, Fealey R, Tuck RR. Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clinic Proc. 1983;58:583-592.
16. Tooke JE, Ostergren J, Fagrell B. Synchronous assessment of human skin microcirculation by laser Doppler flowmetry and dynamic capillaroscopy. Int J Microcirc Clin Exp. 1983;2:277-284.
17. Grant RT, Bland EF. Observations on arteriovenous anastomoses in human skin and the bird's foot with special reference to the reaction to cold. Heart. 1931;15:385-407.
18. Hassan AAK, Rayman G, Tooke JE. Effect of indirect heating on the postural control of skin blood flow in the human foot. Clin Sci. 1986;70: 577-582.
19. Mahy IR, Tooke JE, Shore AC. Capillary pressure during and after incremental venous pressure elevation in man. J Physiol. 1995;485: 213-219.
20. Henriksen O, Sejrsen P, Paaske WP, Eickhoff JH. Effect of chronic sympathetic denervation upon the transcapillary filtration rate induced by venous stasis. Acta Physiol Scand. 1983;117:171-176.
21. Henriksen O, Nielsen SL, Paaske WP, Sejrsen P. Autoregulation of blood flow in human cutaneous tissue. Acta Physiol Scand. 1973;89:538-543.
22. Noddeland H, Aukland K, Nicolaysen G. Plasma colloid osmotic pressure in venous blood from the human foot in orthostasis. Acta Physiol Scand. 1981;113:447-454.
23. Williams SA, Rayman G, Tooke JE. Dependent oedema and attenuation of postural vasoconstriction associated with nifedipine therapy for hypertension in diabetic patients. Eur J Clin Pharmacol. 1989;37:333-335.
24. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Ann Rev Pharmacol Toxicol. 1977;17:149-166.
25. Gustaffson D, Grande PO, Borgstrom P, Lindberg L. Effect of calcium antagonists on myogenic tone and neurogenic control of resistance and capacitance vessels in cat skeletal muscle. J Cardiovasc Pharmacol. 1988;12:213-222.
26. Subramanian VB. Calcium antagonists in chronic stable angina pectoris. Amsterdam: Excerpta Medica. 1983;97-116:152-156, 217-229.
27. Nilsson P, Lindholm LH, Hedner T. The Diltiazem Different Doses Study: a dose-response study of once-daily diltiazem therapy for hypertension. J Cardiovasc Pharmacol. 1996;27:469-475.
28. Renkin EM. Some consequences of capillary permeability to macromolecules: Starling's hypothesis reconsidered. Am J Physiol. 1986;250: H706-H710.
29. Stornello M, Di Rao G, Iachello M, Pisani R, Scapellato L, Pedrinelli R, Salvetti A. Hemodynamic and humoral interactions between captopril and nifedipine. Hypertension. 1983;5(pt 2):154-156.
30. Ondetti MA. Angiotensin converting enzyme inhibitors. an overview. Hypertension. 1991;18(suppl III):III-134-III-135.
31. Gustafsson D, Lanne T, Bjerkhoel P, Joansson P, Lundvall J. Microvascular effects and oedema formation of felodipine in man. J Hypertens. 1989;7:S161-S167.
32. Abrams WB, Davies RO, Ferguson RK. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Fed Proc. 1984;43:1314-1321.